Nivolumab
- PDF / 168,914 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 3 Downloads / 161 Views
1 S
Nivolumab Encephalitis: case report
A 75-year-old woman developed encephalitis during treatment with nivolumab for metastatic lung cancer. The woman, who had metastatic lung cancer presented with cognitive dysfunction and seizure after 4 weeks of treatment with nivolumab [route and dosage not stated]. Her brain MRI was normal; however, CSF analysis revealed mild pleocytosis and EEG showed diffusely slow tracing. She was diagnosed with nivolumab-induced seronegative encephalitis. Thus, her nivolumab therapy was discontinued and she was treated with unspecified steroids. After 2 months, her neurological status improved. Cabral G, et al. Nivolumab induced-encephalitis. European Journal of Neurology 27 (Suppl. 1): 975 abstr. EPO2338, May 2020. Available from: URL: https:// onlinelibrary.wiley.com/toc/14681331/2020/27/S1 [abstract]
0114-9954/20/1819-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
803498561
Reactions 29 Aug 2020 No. 1819
Data Loading...
